A matched case-controlled study of 48 an
โ
Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji;
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 122 KB
๐ 1 views
## Abstract Substitution of amino acid (aa) 70 and 91 in the core region of HCV genotype 1b is a useful pretreatment predictor of efficacy of 48โweek peginterferon (PEGโIFN) plus ribavirin (RBV) therapy. Here, we determined the efficacy of 72โweek PEGโIFN/RBV and the predictive factors to such ther